AB 2180 — Health care coverage: cost sharing.
Last action — In committee: Held under submission.
-
✓Introduced
-
2In Committee
-
3Passed Assembly
-
4Passed Senate
-
5To Executive
-
6Enacted
This bill died with 2023-2024 Regular Session. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
This bill is no longer active — its legislative session has ended, so there are no live odds of enactment. It would have to be reintroduced in the current session to move again.
Summary
Existing law generally prohibits a person who manufactures a prescription drug from offering in California any discount, repayment, product voucher, or other reduction in an individual's out-of-pocket expenses associated with the individual's health insurance, health care service plan, or other health coverage, including, but not limited to, a copayment, coinsurance, or deductible, for any prescription drug if a lower cost generic drug is covered under the individual's health insurance, health care service plan, or other health coverage on a lower cost-sharing tier that is designated as therapeutically equivalent to the prescription drug manufactured by that person or if the active ingredients of the drug are contained in products regulated by the federal Food and Drug Administration, are available without prescription at a lower cost, and are not otherwise contraindicated for the condition for which the prescription drug is approved. Existing law, the Knox-Keene Health Care Service Plan Act of 1975, provides for the licensure and regulation of health care service plans by the Department of Managed Health Care, and makes a willful violation of the act a crime. Existing law provides for the regulation of health insurers by the Department of Insurance. This bill would require a health care service plan, health insurance policy, or pharmacy benefit manager that administers pharmacy benefits for a health care service plan or health insurer to apply any amounts paid by the enrollee, insured, or a third-party patient assistance program for prescription drugs toward the enrollee's or insured's cost-sharing requirement, and would only apply those requirements with respect to enrollees or insureds who have a chronic disease or terminal illness. The bill would limit the application of the section to health care service plans and health insurance policies issued, amended, delivered, or renewed on or after January 1, 2025. The bill would repeal those provisions on January 1, 2035. The bill would require the Department of Managed Health Care and the Department of Insurance, by March 31, 2034, to provide a report to the appropriate policy committees of the Legislature on the impact of the provisions on drug prices and health care premium rates, including a recommendation whether the repeal date should be deleted. Existing law requires a health care service plan or health insurer that files certain rate information to report to the appropriate department specified cost information regarding covered prescription drugs, including generic drugs, brand name drugs, and specialty drugs, dispensed as provided. This bill, until January 1, 2035, additionally would require health care service plans and health insurers to report the 25 most frequently prescribed drugs with a patient assistance program, as described in the bill, and the 25 most costly drugs, by total annual plan spending, with a prescription assistance program, as described in the bill. The bill also would require the health care service plan or health insurer to report the aggregate dollar amount of all patient assistance programs that the health care service plan, health insurer, or their designee collected from all third-party entities in connection with the bill's cost-sharing requirements that are attributable to drug utilization by enrollees or insureds during that calendar year. Because a willful violation of the bill's requirements by a health care service plan would be a crime, this bill would impose a state-mandated local program. The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement. This bill would provide that no reimbursement is required by this act for a specified reason.
Bill Text
- Amended 04/30/24 - Amended Assembly Current pdf April 30, 2024
- Amended 04/10/24 - Amended Assembly pdf April 10, 2024
- Introduced 02/07/24 - Introduced pdf February 07, 2024
- AB2180 View text html
Action History
-
In committee: Held under submission.
-
Joint Rule 62(a), file notice suspended. (Page 5215.)
-
In committee: Set, first hearing. Referred to APPR. suspense file.
-
Re-referred to Com. on APPR.
-
Read second time and amended.
-
From committee: Amend, and do pass as amended and re-refer to Com. on APPR. (Ayes 16. Noes 0.) (April 23).
-
Re-referred to Com. on HEALTH.
-
From committee chair, with author's amendments: Amend, and re-refer to Com. on HEALTH. Read second time and amended.
-
Referred to Com. on HEALTH.
-
From printer. May be heard in committee March 9.
-
Read first time. To print.
Sponsors
- Weber Pierson, M.D., Akilah · Primary
Sponsorship breakdown
Export CSV (upgrade) →1 sponsors · 0 co-sponsors · 121 not signed on
Sponsors (1)
- Weber Pierson, M.D., Akilah Democratic
Co-sponsors (0)
None.
Not signed on (121)
121 members have not signed on to this bill.
Show all 121 →"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.
Votes
| Party | Yea | Nay | Present | Not Voting |
|---|---|---|---|---|
| Republican | 3 | 0 | 0 | 0 |
| Democratic | 6 | 0 | 0 | 0 |
| Unaffiliated | 7 | 0 | 0 | 0 |
| Total | 16 | 0 | 0 | 0 |
| % of votes cast | 100% | 0% | 0% | 0% |
How each member voted (16)
| Member | Party | Vote |
|---|---|---|
| Rodriguez | — | Yea |
| Maienschein | — | Yea |
| Jones-Sawyer | — | Yea |
| Waldron | — | Yea |
| Santiago | — | Yea |
| McCarty | — | Yea |
| Wendy Carrillo | — | Yea |
| Aguiar-Curry, Cecilia M. | Democratic | Yea |
| Arambula, Joaquin | Democratic | Yea |
| Bonta, Mia | Democratic | Yea |
| Haney, Matt | Democratic | Yea |
| Schiavo, Pilar | Democratic | Yea |
| Weber Pierson, M.D., Akilah | Democratic | Yea |
| Flora, Heath | Republican | Yea |
| Patterson, Joe | Republican | Yea |
| Sanchez, Kate | Republican | Yea |
Subjects
Frequently asked questions
- What does AB 2180 do?
- Existing law generally prohibits a person who manufactures a prescription drug from offering in California any discount, repayment, product voucher, or other reduction in an individual's out-of-pocket expenses associated with the individual's health insurance, health care service plan, or other health coverage, including, but not limited to, a copayment, coinsurance, or deductible, for any prescription drug if a lower cost generic drug is covered under the individual's health insurance, health care service plan, or other health coverage on a lower cost-sharing tier that is designated as therapeutically equivalent to the prescription drug manufactured by that person or if the active ingredients of the drug are contained in products regulated by the federal Food and Drug Administration, are available without prescription at a lower cost, and are not otherwise contraindicated for the condition for which the prescription drug is approved. Existing law, the Knox-Keene Health Care Service Plan Act of 1975, provides for the licensure and regulation of health care service plans by the Department of Managed Health Care, and makes a willful violation of the act a crime. Existing law provides for the regulation of health insurers by the Department of Insurance. This bill would require a health care service plan, health insurance policy, or pharmacy benefit manager that administers pharmacy benefits for a health care service plan or health insurer to apply any amounts paid by the enrollee, insured, or a third-party patient assistance program for prescription drugs toward the enrollee's or insured's cost-sharing requirement, and would only apply those requirements with respect to enrollees or insureds who have a chronic disease or terminal illness. The bill would limit the application of the section to health care service plans and health insurance policies issued, amended, delivered, or renewed on or after January 1, 2025. The bill would repeal those provisions on January 1, 2035. The bill would require the Department of Managed Health Care and the Department of Insurance, by March 31, 2034, to provide a report to the appropriate policy committees of the Legislature on the impact of the provisions on drug prices and health care premium rates, including a recommendation whether the repeal date should be deleted. Existing law requires a health care service plan or health insurer that files certain rate information to report to the appropriate department specified cost information regarding covered prescription drugs, including generic drugs, brand name drugs, and specialty drugs, dispensed as provided. This bill, until January 1, 2035, additionally would require health care service plans and health insurers to report the 25 most frequently prescribed drugs with a patient assistance program, as described in the bill, and the 25 most costly drugs, by total annual plan spending, with a prescription assistance program, as described in the bill. The bill also would require the health care service plan or health insurer to report the aggregate dollar amount of all patient assistance programs that the health care service plan, health insurer, or their designee collected from all third-party entities in connection with the bill's cost-sharing requirements that are attributable to drug utilization by enrollees or insureds during that calendar year. Because a willful violation of the bill's requirements by a health care service plan would be a crime, this bill would impose a state-mandated local program. The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement. This bill would provide that no reimbursement is required by this act for a specified reason.
- Who sponsors AB 2180?
- AB 2180 is sponsored by Weber Pierson, M.D., Akilah (Democratic).
- What is the current status of AB 2180?
- This bill died with 2023-2024 Regular Session. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
- Where can I track AB 2180?
- Track AB 2180 free on One Click Politics — get push/email alerts when it moves.
Make your voice heard on AB 2180
Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.
Stay ahead of AB 2180
Last checked for changes 2 months ago · updated continuously
One Click Politics tracks every bill in Congress and all 50 states.
Track this bill →